BioSpace News Archive

Keymed Biosciences announced that the Center for Drug Evaluation of the China National Medical Products Administration has granted CMG901 the Breakthrough Therapy Designation for the treatment of advanced gastric and gastroesophageal junction cancer which have relapsed and/or are intolerant to prior therapies.

Spexis AG, a clinical-stage biopharmaceutical company focused on rare diseases and oncology, announced the results of a Phase 1 clinical trial with balixafortide, a potent, specific and highly selective macrocycle inhibitor of CXCR4.

Sensorion announces its half-year results as of June 30, 2022, alongside its outlook for the remainder of 2022.

RELIEF THERAPEUTICS Holding SA announced that an Investigator Initiated Trial with Nexodyn for Epidermolysis Bullosa has received IRB approval and will shortly enroll participants at Ann & Robert H. Lurie Children’s Hospital of Chicago with Professor Amy Paller, M.D., Chair, Department of Dermatology, Feinberg School of Medicine, Northwestern University, serving as Principal Investigator.

GSK and Spero Therapeutics, Inc. announced they have entered into an exclusive license agreement for Spero’s late-stage antibiotic asset, tebipenem HBr.

Vicore Pharma Holding AB, a clinical-stage pharmaceutical company developing medicines stimulating the angiotensin II type 2 receptor, announces that intra-arterial administration of C21 results in a significant dose-dependent increase in local blood flow.

Inventiva reported its interim financial results for the six months ended June 30, 2022, and provided a corporate update.

Agilis Robotics Limited has announced its fund-raising status, as well as its latest technological achievements.

AlzeCure Pharma AB announced that the company’s presentation from the pain conference IASP 2022 is now available in its entirety on the company’s website.

Laxxon Medical Corp. announced that the United States Patent and Trademark Office has issued U.S. Patent 11,419,824 B2 for the controlled administration of one or more active pharmaceutical ingredients within a drug delivery system via oral dosage forms.